Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:55
Bayer Plunges on Drug Setback, $1.5 Billion Roundup Verdict
Bayer AG faces two fresh setbacks, causing the stock to plummet, after stopping the main study of its
2023-11-20 16:52